|
RNF185 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.03600000040439E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.47719999999507E-05 |
| Normal-vs-Stage2 |
5.178800E-01 |
| Normal-vs-Stage3 |
2.86800000415255E-08 |
| Normal-vs-Stage4 |
5.12159999965789E-08 |
| Stage1-vs-Stage2 |
2.145200E-01 |
| Stage1-vs-Stage3 |
4.457900E-02 |
| Stage1-vs-Stage4 |
1.059550E-02 |
| Stage2-vs-Stage3 |
4.753800E-02 |
| Stage2-vs-Stage4 |
1.616180E-02 |
| Stage3-vs-Stage4 |
2.562200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.82819999641859E-08 |
| Normal-vs-AfricanAmerican |
5.54039999999256E-05 |
| Normal-vs-Asian |
3.064900E-03 |
| Caucasian-vs-AfricanAmerican |
5.218600E-01 |
| Caucasian-vs-Asian |
2.714400E-01 |
| AfricanAmerican-vs-Asian |
2.007400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.92160000040454E-07 |
| Normal-vs-Female |
1.71369999999449E-05 |
| Male-vs-Female |
1.619380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.0654999999925E-05 |
| Normal-vs-Age(41-60Yrs) |
2.26819999999961E-05 |
| Normal-vs-Age(61-80Yrs) |
4.97439999969096E-07 |
| Normal-vs-Age(81-100Yrs) |
1.720330E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.302000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.358800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.707400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.748000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.722000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.743000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.581900E-02 |
| Classical-VS-Follicular |
5.955900E-02 |
| Classical-VS-Other |
1.474790E-01 |
| Classical-VS-Normal |
1.63760000004842E-06 |
| Tall-VS-Follicular |
7.036500E-03 |
| Tall-VS-Other |
5.074600E-01 |
| Tall-VS-Normal |
1.55139999957754E-07 |
| Follicular-VS-Other |
2.066400E-01 |
| Follicular-VS-Normal |
3.002400E-01 |
| Other-VS-Normal |
4.365600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.006600E-04 |
| Normal-vs-N1 |
8.47449999952232E-07 |
| N0-vs-N1 |
2.237500E-02 |
|
|
